ArcticBlast for Arthritis: 8-Week Test for OA and RA (2026)
Arthritis pain management is a long game. The two most common forms — osteoarthritis (OA) and rheumatoid arthritis (RA) — both cause joint pain, but through different mechanisms, and both respond differently to topical treatment. What makes ArcticBlast particularly relevant is its DMSO carrier, which allows active ingredients to penetrate into joint tissue rather than staying at the skin surface.
We tested ArcticBlast with two arthritis patients over 8 weeks — one OA (knee and hip), one RA (hands and wrists). The results were meaningfully different between the two conditions, and that distinction matters for setting expectations.
How DMSO Works for Arthritis
DMSO (dimethyl sulfoxide) is the delivery mechanism that separates ArcticBlast from standard menthol gels. In arthritis specifically, there are two relevant effects:
- Deep penetration into joint tissue: DMSO carries co-dissolved ingredients (menthol, camphor, aloe vera) through skin and soft tissue into the joint capsule and surrounding synovial tissue. This is deeper than diclofenac gel or menthol products typically reach.
- DMSO’s own anti-inflammatory properties: DMSO has been studied as an anti-inflammatory agent independently of its carrier function. It scavenges hydroxyl free radicals, which are involved in joint tissue degradation in both OA and RA. This is separate from the menthol cooling effect.
For OA, where the primary issue is cartilage degradation and local joint inflammation, topical DMSO-based products are well-suited. For RA, which involves systemic immune dysregulation, topical products address the local joint inflammation component but don’t affect the underlying autoimmune process.
Osteoarthritis vs Rheumatoid Arthritis — What to Expect
- Osteoarthritis: Mechanical wear and inflammatory response in load-bearing joints (knees, hips, hands, spine). ArcticBlast works well here — the DMSO reaches the joint space, reduces local inflammation, and the cooling effect provides sustained pain relief. Our knee and hip pain pages document specific test results by joint.
- Rheumatoid Arthritis: Autoimmune synovial inflammation, typically in smaller joints (fingers, wrists, feet), symmetrical. ArcticBlast provides good local relief for active joint flares but doesn’t affect disease activity or progression. It works best as a complement to DMARDs or biologics rather than as standalone treatment.
- Psoriatic arthritis: Similar to RA but associated with psoriasis. Topical DMSO caution applies — avoid applying to actively psoriatic skin.
- Gout: Uric acid crystal deposits, typically first metatarsophalangeal joint. ArcticBlast can reduce local inflammation during a gout flare, but avoid applying during the acute hyperinflammatory phase when the joint is extremely sensitive and hot.
Our 8-Week Test
Tester 1 — Margaret, 67 (Bilateral Knee OA + Left Hip OA)
Margaret has grade 3 OA in both knees (confirmed radiographically) and moderate OA in the left hip. She uses a walking aid on bad days. Baseline pain: 6/10 right knee, 5.5/10 left knee, 5/10 left hip. She applied ArcticBlast to all three joints 3x daily — morning, mid-afternoon, and before bed.
Week 1: Knee pain reduced to 4.5/10 right, 4/10 left within the first week. Morning stiffness duration dropped from 40 minutes to 25 minutes. Hip showed slower response — hip joint is deeper and has more surrounding tissue than the knee.
Week 3: Knees at 3.5/10, hip at 4/10. Margaret began walking without her aid on low-pain days. Night pain — which had been disrupting sleep 3–4 times per week — dropped to 1–2 disruptions. The pre-bed application was the most consistently helpful.
Week 6: Knees 2.5–3/10. Hip 3.5/10. Paracetamol use reduced from daily to 3–4x per week. Margaret reports the most significant change is in morning function — the time before she can move comfortably has roughly halved since starting ArcticBlast.
Week 8: Knees 2.5/10 (stable). Hip 3/10. She considers ArcticBlast her most effective daily pain management tool, used alongside her prescribed glucosamine supplement. The consistency of relief across 8 weeks — no tolerance development — is her main positive finding.
Tester 2 — David, 58 (Rheumatoid Arthritis — Hands, Wrists, Knees)
David has seropositive RA managed with methotrexate. His disease activity is moderate — some days functional, some days significantly limited. He tested ArcticBlast on his hands, wrists, and right knee during a period of stable disease activity. Baseline pain during active periods: 6/10 hands/wrists, 5/10 right knee.
Week 1–2: Local relief was rapid — 15–20 minutes per application, relief lasting 90–100 minutes. David noted this is faster than the Voltaren he previously used. Hands and wrist benefited most; the finger joints responded particularly well to small-drop targeted application.
Week 4: Pain during active periods 4/10 hands, 3.5/10 knee. Crucially, David had a mild flare in week 3 — during which ArcticBlast still provided local relief but with shorter duration (60–70 minutes vs the usual 90–100). This reflects RA’s systemic nature: local topicals are limited during high-activity flares.
Week 8: David’s conclusion is nuanced: ArcticBlast is “excellent for daily management” of RA joint pain between flares, and “helpful but not sufficient alone” during active flares. He now uses it as first-line response to joint pain onset, escalating to his prescribed NSAIDs only when topical relief is insufficient.
ArcticBlast vs Other Arthritis Treatments
| Treatment | OA | RA | Prescription? | Notes |
|---|---|---|---|---|
| ArcticBlast (DMSO) | Excellent | Good (local) | No | Best topical penetration; daily use safe |
| Voltaren Gel (diclofenac) | Good | Good (local) | No | Well-studied for OA; moderate penetration |
| Menthol gel | Moderate | Moderate | No | Fast but short relief; surface only |
| Oral NSAIDs | Good | Good | No (OTC)/Yes | GI risk long-term; better for systemic RA |
| DMARDs / biologics | N/A | Excellent | Yes | Disease-modifying; essential for RA |
| Glucosamine/chondroitin | Modest (OA) | N/A | No | Some evidence for OA; slow effect |
→ Try ArcticBlast for arthritis pain — official site with money-back guarantee
Specific Joint Guides
- ArcticBlast for Knee Pain — detailed knee OA application and test results
- ArcticBlast for Hip Pain — hip OA and bursitis results
- ArcticBlast for Wrist and Hand Pain — wrist/finger joint results, including RA
- ArcticBlast for Back Pain — spinal OA and facet joint results
- ArcticBlast Full Review — complete 8-week independent test
Frequently Asked Questions
Does ArcticBlast work for arthritis pain?
Yes. ArcticBlast’s DMSO carrier penetrates more deeply into joint tissue than standard topicals, and DMSO itself has anti-inflammatory properties that complement the menthol and camphor active ingredients. In our 8-week test, OA patients saw significant pain reduction; RA patients saw good local relief between flares, with more limited effect during high-activity flare periods.
Is ArcticBlast safe to use long-term for arthritis?
DMSO is generally considered safe for long-term topical use. It’s non-addictive and doesn’t carry the GI, cardiovascular, or renal risks associated with long-term oral NSAID use. The main consideration is the temporary garlic-like breath odour from DMSO, which is harmless but noticeable. There are no known cumulative toxicity issues at standard topical doses.
Can I use ArcticBlast with my arthritis medication?
In most cases yes — topical application doesn’t typically interact with oral DMARDs, biologics, or oral NSAIDs. However, DMSO’s penetration-enhancing properties mean it can theoretically increase absorption of anything on the skin surface. Do not apply ArcticBlast directly over other topical medications (like Voltaren) at the same time without consulting your doctor. Apply to different areas or at different times.
Does ArcticBlast work better for OA or RA?
OA responds better to ArcticBlast than RA, based on our testing. OA is primarily a local joint condition where DMSO’s penetration directly addresses the pain source. RA involves systemic immune processes that topical treatment can’t reach — ArcticBlast provides excellent local relief for RA but doesn’t affect disease activity. For RA, it works best as a complement to prescribed disease-modifying treatment.
Related: our full ArcticBlast review.
